Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0428
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial ; volume:63 ; number:4 ; day:27 ; month:1 ; year:2020 ; pages:698-710 ; date:4.2020
Diabetologia ; 63, Heft 4 (27.1.2020), 698-710, 4.2020
- Urheber
-
Philis-Tsimikas, Athena
Klonoff, David C.
Khunti, Kamlesh
Bajaj, Harpreet S.
Leiter, Lawrence A.
Hansen, Melissa V.
Troelsen, Lone N.
Ladelund, Steen
Heller, Simon
Pieber, Thomas R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-019-05080-9
- URN
-
urn:nbn:de:101:1-2020052421012630380682
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Philis-Tsimikas, Athena
- Klonoff, David C.
- Khunti, Kamlesh
- Bajaj, Harpreet S.
- Leiter, Lawrence A.
- Hansen, Melissa V.
- Troelsen, Lone N.
- Ladelund, Steen
- Heller, Simon
- Pieber, Thomas R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hypoglycaemia and human insulin
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Glucose-sensitive insulin with attenuation of hypoglycaemia
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials
Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia
Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Hypoglycaemia and human insulin
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Glucose-sensitive insulin with attenuation of hypoglycaemia
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials
Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia
Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Hypoglycaemia and human insulin
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Glucose-sensitive insulin with attenuation of hypoglycaemia
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials
Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia